Market Tracker

12/13 3:34pm ET

Melinta Therapeutics, Inc. (NASDAQ:MLNT)

15.65
Delayed Data
As of 3:19pm ET
 +0.85 / +5.74%
Today’s Change
10.25
Today|||52-Week Range
39.15
+11.79%
Year-to-Date

Today’s Trading

Previous close14.80
Today’s open14.80
Day’s range14.80 - 15.85
Volume161,800
Average volume (3 months)167,333
Market cap$155.4M
Data as of 3:19pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)-11.96%
Earnings growth (this year)+59.62%
Earnings growth (next 5 years)--
Revenue growth (last year)-34.03%
P/E ratioNM
Price/Sales7.82
Price/Book0.85

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...+0.01+0.64%
PPHMPeregrine Pharmaceut...-0.07-1.61%
RDHLRedhill Biopharma Lt...+0.22+4.80%
TRVNTrevena Inc-0.03-1.60%
Data as of 3:33pm ET, 12/13/2017

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.90
Annual revenue (last year)$18.0M
Annual profit (last year)-$118.0M
Net profit margin-654.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Daniel Mark Wechsler
Chief Financial Officer, Secretary &
EVP
Paul Estrem
Corporate headquarters
New Haven, Connecticut

Forecasts